US Stock MarketDetailed Quotes

FMS Fresenius Medical Care

Watchlist

20.100
-0.110-0.54%

Close Apr 26 16:00 ET

20.100
0.0000.00%

Post 16:00 ET

11.80BMarket Cap22.04P/E (TTM)

Fresenius Medical Care Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

21.29%2.63B

19.91%719.07M

15.53%759.76M

34.11%1.01B

-10.00%142.84M

-12.94%2.17B

-10.37%599.66M

-4.93%657.61M

-18.47%751M

-23.57%158.7M

Net income from continuing operations

-18.10%732.46M

32.55%256.6M

-48.02%147.06M

-5.37%194.95M

-36.80%133.85M

-26.64%894.33M

-36.27%193.58M

-14.58%282.93M

-26.35%206M

-30.40%211.81M

Operating gains losses

18.78%-134.69M

88.57%-5.95M

85.75%-23.75M

---51.58M

-278.21%-53.41M

-244.85%-165.83M

-206.21%-52.01M

-285.47%-166.71M

----

60.53%-14.12M

Depreciation and amortization

-4.70%1.75B

-13.90%425.93M

-9.55%454.03M

2.89%434.19M

4.50%437.81M

13.22%1.84B

13.17%494.67M

24.61%501.98M

6.69%422M

7.92%418.96M

Deferred tax

-194.54%-122.15M

-275.36%-32.63M

-1,112.45%-30.98M

---36.16M

-140.70%-22.37M

-161.66%-41.47M

-76.76%18.61M

-87.24%3.06M

----

-53.53%-9.3M

Other non cash items

15.03%336.42M

12.32%84.59M

15.99%88.72M

--80.54M

19.50%82.57M

4.30%292.48M

12.90%75.32M

11.76%76.49M

----

-9.17%69.1M

Change In working capital

538.27%561.28M

117.88%122.24M

334.94%328.29M

264.57%448.42M

17.18%-337.67M

-30.99%-128.07M

142.06%56.11M

124.21%75.48M

-68.54%123M

-4.79%-407.7M

-Change in receivables

-225.27%-151.84M

-1,916.20%-75.81M

-139.63%-48.01M

85.78%328.82M

-42.46%-356.85M

71.40%-46.68M

94.87%-3.76M

-116.88%-20.04M

-34.92%177M

47.87%-250.5M

-Change in inventory

93.57%-13.14M

220.61%42.49M

208.51%55.05M

60.20%-22.29M

-42.44%-88.39M

-320.99%-204.31M

-133.52%-35.23M

-33.71%-50.73M

24.61%-56M

-49.82%-62.06M

-Change in payables and accrued expense

1,966.22%580.56M

182.69%65.32M

157.42%325.43M

--74.1M

175.63%115.72M

38.08%-31.11M

59.99%-78.99M

10,336.60%126.42M

----

-306.01%-152.99M

-Change in other current assets

-5.41%145.7M

-48.16%90.24M

-121.09%-4.18M

--67.78M

-114.08%-8.15M

-6.19%154.03M

440.17%174.09M

143.25%19.82M

----

-66.09%57.85M

-Change in other working capital

----

--2M

----

Cash from discontinued investing activities

Operating cash flow

21.29%2.63B

19.91%719.07M

15.53%759.76M

34.11%1.01B

-10.00%142.84M

-12.94%2.17B

-10.37%599.66M

-4.93%657.61M

-18.47%751M

-23.57%158.7M

Investing cash flow

Cash flow from continuing investing activities

25.93%-544.23M

57.10%-96.5M

-49.92%-151.1M

60.55%-133.35M

22.73%-163.28M

38.58%-734.73M

46.80%-224.95M

66.43%-100.79M

-35.67%-338M

5.68%-211.32M

Capital expenditure reported

----

---169M

----

Net PPE purchase and sale

2.81%-668.46M

-18.26%-238.87M

14.62%-133.75M

8.08%-155.34M

12.11%-140.49M

17.13%-687.78M

24.83%-201.98M

13.48%-156.66M

16.02%-169M

10.66%-159.85M

Net business purchase and sale

13,226.75%137M

953.30%132.52M

-117.55%-6.58M

--2.99M

136.25%8.07M

100.27%1.03M

86.34%-15.53M

126.56%37.5M

----

78.72%-22.27M

Net investment purchase and sale

73.38%-12.77M

232.54%9.85M

-158.65%-10.77M

--19.01M

-5.69%-30.86M

-410.79%-47.97M

81.60%-7.43M

-16.49%18.36M

----

-149.05%-29.2M

Cash from discontinued investing activities

Investing cash flow

25.93%-544.23M

57.10%-96.5M

-49.92%-151.1M

60.55%-133.35M

22.73%-163.28M

38.58%-734.73M

46.80%-224.95M

66.43%-100.79M

-35.67%-338M

5.68%-211.32M

Financing cash flow

Cash flow from continuing financing activities

-14.91%-1.86B

-521.81%-745.65M

17.95%-412.33M

-702.56M

100.76%2.01M

-57.89%-1.62B

66.46%-119.92M

-74.17%-502.53M

-642.42%-266.64M

Net issuance payments of debt

-23.08%-1.26B

-1,172.19%-680.04M

-57.20%-434.59M

--4.31M

79.66%-148.84M

-185.05%-1.02B

81.41%-53.45M

-29.07%-276.45M

----

-3,165.50%-731.64M

Cash dividends paid

16.92%-328.62M

--0

----

-0.79%-395.56M

--0

----

Proceeds from stock option exercised by employees

--0

209.52%20.15M

-99.60%2K

-99.23%6K

----

37.74%792K

Net other financing activities

-23.68%-270.75M

1.27%-65.62M

109.84%22.26M

---378.24M

-67.50%150.85M

21.69%-218.91M

5.78%-66.46M

-200.95%-226.09M

----

869.11%464.21M

Cash from discontinued financing activities

Financing cash flow

-14.91%-1.86B

-521.81%-745.65M

17.95%-412.33M

---702.56M

100.76%2.01M

-57.89%-1.62B

66.46%-119.92M

-74.17%-502.53M

----

-642.42%-266.64M

Net cash flow

Beginning cash position

-14.03%1.27B

41.38%1.57B

32.85%1.36B

--1.22B

-14.03%1.27B

37.00%1.48B

-28.70%1.11B

-27.22%1.02B

----

37.00%1.48B

Current changes in cash

222.38%226.05M

-148.31%-123.09M

261.64%196.32M

--171.24M

94.23%-18.43M

-168.69%-184.71M

328.98%254.8M

-47.24%54.29M

----

-510.21%-319.26M

Effect of exchange rate changes

-213.47%-72.61M

74.57%-24.05M

-51.61%16.74M

---33.83M

-387.47%-31.47M

-117.65%-23.16M

-404.09%-94.56M

-32.15%34.59M

----

-75.27%10.95M

End cash Position

12.05%1.43B

41.38%1.57B

--1.36B

4.31%1.22B

-14.03%1.27B

-28.70%1.11B

----

9.30%1.17B

Free cash flow

34.70%1.94B

26.61%468.79M

25.28%622.98M

107.74%851.74M

120.77%704K

-11.73%1.44B

-8.09%370.28M

0.03%497.27M

-42.40%410M

-114.52%-3.39M

Currency Unit

EUR

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	21.29%2.63B	19.91%719.07M	15.53%759.76M	34.11%1.01B	-10.00%142.84M	-12.94%2.17B	-10.37%599.66M	-4.93%657.61M	-18.47%751M	-23.57%158.7M
Net income from continuing operations	-18.10%732.46M	32.55%256.6M	-48.02%147.06M	-5.37%194.95M	-36.80%133.85M	-26.64%894.33M	-36.27%193.58M	-14.58%282.93M	-26.35%206M	-30.40%211.81M
Operating gains losses	18.78%-134.69M	88.57%-5.95M	85.75%-23.75M	---51.58M	-278.21%-53.41M	-244.85%-165.83M	-206.21%-52.01M	-285.47%-166.71M	----	60.53%-14.12M
Depreciation and amortization	-4.70%1.75B	-13.90%425.93M	-9.55%454.03M	2.89%434.19M	4.50%437.81M	13.22%1.84B	13.17%494.67M	24.61%501.98M	6.69%422M	7.92%418.96M
Deferred tax	-194.54%-122.15M	-275.36%-32.63M	-1,112.45%-30.98M	---36.16M	-140.70%-22.37M	-161.66%-41.47M	-76.76%18.61M	-87.24%3.06M	----	-53.53%-9.3M
Other non cash items	15.03%336.42M	12.32%84.59M	15.99%88.72M	--80.54M	19.50%82.57M	4.30%292.48M	12.90%75.32M	11.76%76.49M	----	-9.17%69.1M
Change In working capital	538.27%561.28M	117.88%122.24M	334.94%328.29M	264.57%448.42M	17.18%-337.67M	-30.99%-128.07M	142.06%56.11M	124.21%75.48M	-68.54%123M	-4.79%-407.7M
-Change in receivables	-225.27%-151.84M	-1,916.20%-75.81M	-139.63%-48.01M	85.78%328.82M	-42.46%-356.85M	71.40%-46.68M	94.87%-3.76M	-116.88%-20.04M	-34.92%177M	47.87%-250.5M
-Change in inventory	93.57%-13.14M	220.61%42.49M	208.51%55.05M	60.20%-22.29M	-42.44%-88.39M	-320.99%-204.31M	-133.52%-35.23M	-33.71%-50.73M	24.61%-56M	-49.82%-62.06M
-Change in payables and accrued expense	1,966.22%580.56M	182.69%65.32M	157.42%325.43M	--74.1M	175.63%115.72M	38.08%-31.11M	59.99%-78.99M	10,336.60%126.42M	----	-306.01%-152.99M
-Change in other current assets	-5.41%145.7M	-48.16%90.24M	-121.09%-4.18M	--67.78M	-114.08%-8.15M	-6.19%154.03M	440.17%174.09M	143.25%19.82M	----	-66.09%57.85M
-Change in other working capital	----	----	----	----	----	----	----	----	--2M	----
Cash from discontinued investing activities
Operating cash flow	21.29%2.63B	19.91%719.07M	15.53%759.76M	34.11%1.01B	-10.00%142.84M	-12.94%2.17B	-10.37%599.66M	-4.93%657.61M	-18.47%751M	-23.57%158.7M
Investing cash flow
Cash flow from continuing investing activities	25.93%-544.23M	57.10%-96.5M	-49.92%-151.1M	60.55%-133.35M	22.73%-163.28M	38.58%-734.73M	46.80%-224.95M	66.43%-100.79M	-35.67%-338M	5.68%-211.32M
Capital expenditure reported	----	----	----	----	----	----	----	----	---169M	----
Net PPE purchase and sale	2.81%-668.46M	-18.26%-238.87M	14.62%-133.75M	8.08%-155.34M	12.11%-140.49M	17.13%-687.78M	24.83%-201.98M	13.48%-156.66M	16.02%-169M	10.66%-159.85M
Net business purchase and sale	13,226.75%137M	953.30%132.52M	-117.55%-6.58M	--2.99M	136.25%8.07M	100.27%1.03M	86.34%-15.53M	126.56%37.5M	----	78.72%-22.27M
Net investment purchase and sale	73.38%-12.77M	232.54%9.85M	-158.65%-10.77M	--19.01M	-5.69%-30.86M	-410.79%-47.97M	81.60%-7.43M	-16.49%18.36M	----	-149.05%-29.2M
Cash from discontinued investing activities
Investing cash flow	25.93%-544.23M	57.10%-96.5M	-49.92%-151.1M	60.55%-133.35M	22.73%-163.28M	38.58%-734.73M	46.80%-224.95M	66.43%-100.79M	-35.67%-338M	5.68%-211.32M
Financing cash flow
Cash flow from continuing financing activities	-14.91%-1.86B	-521.81%-745.65M	17.95%-412.33M	-702.56M	100.76%2.01M	-57.89%-1.62B	66.46%-119.92M	-74.17%-502.53M		-642.42%-266.64M
Net issuance payments of debt	-23.08%-1.26B	-1,172.19%-680.04M	-57.20%-434.59M	--4.31M	79.66%-148.84M	-185.05%-1.02B	81.41%-53.45M	-29.07%-276.45M	----	-3,165.50%-731.64M
Cash dividends paid	16.92%-328.62M	--0	--0	----	----	-0.79%-395.56M	--0	--0	----	----
Proceeds from stock option exercised by employees	--0	--0	--0	--0	--0	209.52%20.15M	-99.60%2K	-99.23%6K	----	37.74%792K
Net other financing activities	-23.68%-270.75M	1.27%-65.62M	109.84%22.26M	---378.24M	-67.50%150.85M	21.69%-218.91M	5.78%-66.46M	-200.95%-226.09M	----	869.11%464.21M
Cash from discontinued financing activities
Financing cash flow	-14.91%-1.86B	-521.81%-745.65M	17.95%-412.33M	---702.56M	100.76%2.01M	-57.89%-1.62B	66.46%-119.92M	-74.17%-502.53M	----	-642.42%-266.64M
Net cash flow
Beginning cash position	-14.03%1.27B	41.38%1.57B	32.85%1.36B	--1.22B	-14.03%1.27B	37.00%1.48B	-28.70%1.11B	-27.22%1.02B	----	37.00%1.48B
Current changes in cash	222.38%226.05M	-148.31%-123.09M	261.64%196.32M	--171.24M	94.23%-18.43M	-168.69%-184.71M	328.98%254.8M	-47.24%54.29M	----	-510.21%-319.26M
Effect of exchange rate changes	-213.47%-72.61M	74.57%-24.05M	-51.61%16.74M	---33.83M	-387.47%-31.47M	-117.65%-23.16M	-404.09%-94.56M	-32.15%34.59M	----	-75.27%10.95M
End cash Position	12.05%1.43B	12.05%1.43B	41.38%1.57B	--1.36B	4.31%1.22B	-14.03%1.27B	-14.03%1.27B	-28.70%1.11B	----	9.30%1.17B
Free cash flow	34.70%1.94B	26.61%468.79M	25.28%622.98M	107.74%851.74M	120.77%704K	-11.73%1.44B	-8.09%370.28M	0.03%497.27M	-42.40%410M	-114.52%-3.39M
Currency Unit	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall